UNSPSC 51393304: Dalbraminol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C17H26N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7GDN12Q42M, chemically known as (- )-1-phenoxy-3-((2-((1,3,5-trimethylpyrazol-4-yl)amino)ethyl)amino)-2-propanol. but generally known as dalbraminol, which bears US NIH Compound Identifier 205958. European Medicines Agency schedules Dalbraminol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06889MIG.

UNSPSC 51393304 Dalbraminol, a Commodity code, appears in state and local procurement activity focused on pharmaceutical products and related health-system supplies, though recent opportunities show minimal direct correlation to the code's nominal scope. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford and a two-year initial term plus one-year renewal option. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, soliciting information about vendors' experience with direct contracting for self-insured employers and health plans, flexibility to negotiate based on negotiated net pricing models, and capacity to implement value-based agreements outside traditional pharmacy benefit manager and group purchasing organization channels. Both solicitations involve pharmaceutical supply or pharmacy benefit administration rather than Dalbraminol specifically, suggesting a mismatch between the code's nominal scope and what state and local agencies are actually tagging under it.

Recent activity is limited to these two opportunities spanning Florida and Texas, with no indication of broader geographic concentration or repeat issuing bodies under this Commodity code. The Seminole County IFB required electronic submission through the county's e-Procurement Portal by July 26, 2023, with drug-free workplace and E-Verify compliance mandated; the Texas HHS RFI closed April 3, 2026 and functioned as preliminary market intelligence to inform future formal procurement rather than a binding solicitation. The code shows little relevant recent state and local procurement activity aligned to Dalbraminol as a discrete product line.